The 340B Drug Pricing Program contains several complexities that covered entities are expected to govern and oversee.
Michael Starling, PharmD, MBA, BCPS
Advertisement
Articles by Michael Starling, PharmD, MBA, BCPS
Advertisement
Latest Updated Articles
340B Focus: Working With ConsultantsPublished: September 11th 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
3
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
4
Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education
5
